Decoy Therapeutics annual asset turnover
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Decoy Therapeutics Asset Turnover Growth & History (DCOY)
Decoy Therapeutics's asset turnover was 0.00 for fiscal 2025.
View full Decoy Therapeutics company overviewDecoy Therapeutics annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.00 | 0.00 | — |
| 2024 | 2024-12-31 | 0.00 | 0.00 | — |
| 2023 | 2023-12-31 | 0.00 | 0.00 | — |
| 2022 | 2022-12-31 | 0.00 | −0.06 | — |
| 2021 | 2021-12-31 | 0.06 | −0.21 | −79.24% |
| 2020 | 2020-12-31 | 0.27 | −0.07 | −20.23% |
| 2019 | 2019-12-31 | 0.34 | 0.24 | +260.25% |
| 2018 | 2018-12-31 | 0.09 | 0.07 | +261.39% |
| 2017 | 2017-12-31 | 0.03 | 0.01 | +103.25% |
| 2016 | 2016-12-31 | 0.01 | 0.01 | — |
| 2015 | 2015-12-31 | 0.00 | — | — |
Decoy Therapeutics quarterly asset turnover
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.04 | — | — |
| Q1 2026 | 2026-03-31 | 0.00 | — | — |
| Q4 2025 | 2025-12-31 | 0.00 | — | — |
| Q1 2023 | 2023-03-31 | 0.00 | −0.01 | — |
| Q4 2022 | 2022-12-31 | 0.00 | −0.06 | — |
| Q3 2022 | 2022-09-30 | 0.00 | −0.10 | — |
| Q2 2022 | 2022-06-30 | 0.00 | −0.14 | — |
| Q1 2022 | 2022-03-31 | 0.01 | −0.14 | −91.26% |
| Q4 2021 | 2021-12-31 | 0.06 | −0.21 | −79.24% |
| Q3 2021 | 2021-09-30 | 0.10 | −0.16 | −61.41% |
| Q2 2021 | 2021-06-30 | 0.14 | −0.19 | −57.34% |
| Q1 2021 | 2021-03-31 | 0.15 | −0.13 | −45.68% |
| Q4 2020 | 2020-12-31 | 0.27 | −0.07 | −20.23% |
| Q3 2020 | 2020-09-30 | 0.26 | 0.07 | +40.08% |
| Q2 2020 | 2020-06-30 | 0.33 | 0.15 | +86.15% |
| Q1 2020 | 2020-03-31 | 0.28 | 0.19 | +211.43% |
| Q4 2019 | 2019-12-31 | 0.34 | 0.29 | +565.58% |
| Q3 2019 | 2019-09-30 | 0.18 | 0.14 | +327.63% |
| Q2 2019 | 2019-06-30 | 0.18 | 0.15 | +434.93% |
| Q1 2019 | 2019-03-31 | 0.09 | 0.06 | +201.82% |
| Q4 2018 | 2018-12-31 | 0.05 | 0.02 | +95.61% |
| Q3 2018 | 2018-09-30 | 0.04 | 0.02 | +83.67% |
| Q2 2018 | 2018-06-30 | 0.03 | 0.01 | +45.21% |
| Q1 2018 | 2018-03-31 | 0.03 | 0.01 | +69.12% |
| Q4 2017 | 2017-12-31 | 0.03 | 0.01 | +103.25% |
| Q3 2017 | 2017-09-30 | 0.02 | — | — |
| Q2 2017 | 2017-06-30 | 0.02 | — | — |
| Q1 2017 | 2017-03-31 | 0.02 | — | — |
| Q4 2016 | 2016-12-31 | 0.01 | — | — |
Decoy Therapeutics asset turnover trends
Over the last five fiscal years, Decoy Therapeutics's asset turnover decreased from 0.27 to 0.00, a change of −0.27. The latest reported quarter, Q2 2026, shows 0.04.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Decoy Therapeutics source filings ↗